Bio Protocol vs Codatta — how do they compare? Bio Protocol trades at Rp428.05 (market cap Rp972,61M, Rp151,33M 24h volume), while Codatta trades at Rp125.31 (market cap Rp311,47M, Rp17,15M 24h volume). The key difference: Bio Protocol is far larger — about 3.1× Codatta's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 2,5B / 10B XNY (25%) for Codatta. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Codatta for 4 Days on average.
| BIO | XNY | |
|---|---|---|
Market Cap | Rp972,61M | Rp311,47M |
Volume (24h) | Rp151,33M | Rp17,15M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 2,5B / 10B XNY (25%) |
Typical Hold Time | 18 Days | 4 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
XNY (Codatta) trades at Rp123.31 with a market cap of Rp309.92M, showing a bullish technical signal from moving averages while oscillators are neutral. The asset has a 25% circulating supply (2.5M of 10M max) and short average hold time of 4 days. Key levels show support at Rp120 and resistance at Rp126. No recent protocol updates or major ecosystem news were identified.
Overall outlook is cautiously optimistic due to technical bullishness, but limited by low circulation rate and minimal fundamental catalysts. Key opportunities include potential price movement toward resistance; major risks are low liquidity and lack of recent development activity impacting long-term adoption.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Codatta is a decentralized infrastructure protocol that converts human and AI-generated knowledge into ownable, royalty-generating digital assets. It enables contributors to fractionalize data and earn ongoing revenue streams. Operating across BNB Chain, Ethereum, and Solana, Codatta provides provenance tracking, licensing, and automated payouts as a plug-and-play backend for AI and DeSci ecosystems.
Read more on XNY →